With the 2023-2024 influenza season accelerating in late 2023, a recent study reported good news for seniors also concerned about Respiratory syncytial virus (RSV) disease.
Read More
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
